GPX Medical in Media

We develop technology for improving the care and life quality of our most vulnerable patients – preterm born infants.

New member in SmiLe Incubator

GPX Medical has been elected new member in one of Sweden’s most recognized incubators for Life Sciences companies, SmiLe Incubator in Medicon Village, Lund. The company will get support to commercialize its medical device for 24-hour monitoring of the lungs of...

Ground breaking study published in Journal of Biophotonics

A study concerning a new possibility to develop a light-based surveillance modality for prematurely born infants has been published in the Journal of Biophotonics. The paper “Comparison of dermal versus internal light administration in human lungs using the...

i

4 questions to GPX Medical's CEO

Interview with CEO Hanna Sjöström by Rapidus Business Press 2019-01-22. In Swedish.

i

The Board recruits Hanna Sjöström as new CEO from January 28, 2019.

Powerful investment in GASPOROX subsidiary GPX Medical, the Board recruits Hanna Sjöström as new CEO from January 28, 2019. Pressrelease in English.

i

Light reveals lung function

Interview with GPX Medical’s CTO PhD Sara Bergsten by Elektronik Tidningen 2019-01-10. In Swedish.

i

Precise Wavelength Used to Gently Image Lungs of Newborns

News Articla. Photonics Media June 2016. In English.

i

News Article Läkartidningen

Non invasive optical techniques can register oxygen in tissue 2016-04-01. In Swedish.

i

News Article Medical Xpress

Light can be used to examine lungs of premature babies. 2016-03-22. In English.

i

News Article Dagens Medicin

New technology for lung monitoring. 2015-10-05. In Swedish.

i

Laser analysis can improve lung control

News Article in Sydsvenskan with MD, PhD Emilie Kite Svanberg 2015-10-04. In Swedish.

For Investors

GPX Medical is on a journey to create better care for for our most vulnerable patients.

About GPX Medical

GPX Medical AB was formed in 2016 as a subsidiary to GASPOROX AB (publ), with the aim to develop and commercialize medical applications of GASMAS technology. The company is owned to 60% by GASPOROX AB (publ) and to 40% by Norsk Elektro Optikk AS, and located in Lund, Sweden. Org. nbr. 559069-9012.

For investors

Please contact CEO Hanna Sjöström for investment opportunities:
hs@gpxmedical.se

Contact

GPX Medical AB
Maskinvägen 1
223 70 Lund
Sweden
info@gpxmedical.se